schizandrin b has been researched along with Disease Models, Animal in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 17 (62.96) | 24.3611 |
| 2020's | 8 (29.63) | 2.80 |
| Authors | Studies |
|---|---|
| Pu, Z; Wang, M; Xie, H; Xu, M; Zhang, W; Zhao, J | 1 |
| Chen, J; Huang, Y; Luo, J; Luo, X; Tan, T; Wang, N; Wang, Y; Wei, M; Yang, S; Ye, C; Zhang, J | 1 |
| Chang, JH; Chiang, CY; Chuang, HC; Fan, CK; Hou, TY; Lee, YL; Lin, CL | 1 |
| Jiang, SJ; Lam, HYP; Liang, TR; Peng, SY | 1 |
| Cheon, CK; Lee, JH; Lee, JY | 1 |
| Zhang, PX; Zhao, LK; Zhao, YB | 1 |
| Chen, X; Jiang, Y; Jiang, Z; Li, W; Wang, M; Xiao, Z | 1 |
| Chen, H; Chen, J; Chen, Y; Kong, Y; Li, L; Wang, Q; Xie, H | 1 |
| Han, D; Hu, ZM; Huo, HJ; Qiu, QH; Xin, DQ; Xing, WH; Yang, XJ; Zhao, Y | 1 |
| Chan, CL; Chao, XJ; Fong, WF; Fu, X; Kwan, HY; Liu, B; Su, T; Tse, AKW; Wu, J; Yu, H; Yu, ZL | 1 |
| Chen, ZC; Cheng, DJ; Guo, YL; Li, XS; Ma, LJ; Tang, XY; Tian, CJ; Zhang, LX; Zhang, XY; Zhao, LM | 1 |
| Han, G; Shao, M; Yang, W | 1 |
| Cai, C; Xiang, Y; Zeng, C; Zhao, X; Zhou, A; Zhu, N | 1 |
| Li, M; Li, ZC; Tang, M; Wu, Y; Yao, LQ | 1 |
| Ding, WF; Lin, JR; Qin, JH; Wu, WH | 1 |
| Chen, T; Huang, W; Liang, G; Qian, J; Qian, Y; Wang, J; Wang, Z; Wu, G; You, S | 1 |
| Jia, ZH; Ko, KM; Pan, SY; Sun, N; Wang, XY; Yu, Q; Yu, ZL; Zhang, Y; Zhu, PL | 1 |
| Chen, Y; Li, L; Xin, Y; Xing, G; Zhang, T; Zhou, L | 1 |
| Bi, K; Jia, Y; Li, H; Liu, B; Liu, Z; Mao, X; Zhang, C; Zhao, X | 1 |
| Arumugam, S; Giridharan, VV; Ko, KM; Konishi, T; Krishnamurthy, P; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Chan, CL; Chao, X; Dai, W; Fong, WF; Fu, X; Kwan, HY; Lee, KC; Li, T; Lu, A; Niu, X; Pan, SY; Su, T; Tong, T; Tse, AK; Yi, H; Yu, H; Yu, ZL | 1 |
| Ba, Q; Cui, C; Feng, S; Wen, L; Yang, K; Zhou, J | 1 |
| Bian, H; Cai, J; Cai, Z; Liu, J; Zhu, G | 1 |
| Bonilla, S; Cho, J; Chong, L; Jin, ZB; Ko, KM; Leung, YF; Liu, Y; Ma, P; Pang, CP; Venkatraman, P; Xiang, L; Zhang, L; Zhang, M | 1 |
| Dong, H; Fong, WF; Guo, BF; Han, YF; Ko, KM; Pan, SY; Yu, ZL; Zhang, Y | 1 |
| Dong, H; Han, YF; Ko, KM; Li, WY; Pan, SY; Zhao, XY | 1 |
| Dong, H; Fang, HY; Fong, WF; Ko, KM; Pan, SY; Xiang, CJ; Yu, ZL; Zhao, XY | 1 |
27 other study(ies) available for schizandrin b and Disease Models, Animal
| Article | Year |
|---|---|
Schisandrin B Attenuates Colitis-Associated Colorectal Cancer through SIRT1 Linked SMURF2 Signaling.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colitis-Associated Neoplasms; Cyclooctanes; Disease Models, Animal; Humans; Lignans; Male; Mice; Mice, Inbred C57BL; Polycyclic Compounds; Sirtuin 1; Ubiquitin-Protein Ligases | 2021 |
Schisandrin B suppresses osteosarcoma lung metastasis
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooctanes; Disease Models, Animal; Humans; Lignans; Lung Neoplasms; Mice; Osteosarcoma; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Proto-Oncogene Proteins c-akt; Wnt Signaling Pathway | 2022 |
Schisandrin B promotes Foxp3
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Asthma; Cyclooctanes; Dendritic Cells; Disease Models, Animal; Forkhead Transcription Factors; Heme Oxygenase-1; Hypersensitivity; Immunoglobulin E; Immunomodulating Agents; Lignans; Mice; Mice, Inbred BALB C; Polycyclic Compounds; Respiratory Hypersensitivity; T-Lymphocytes, Regulatory; Th2 Cells | 2022 |
Albendazole-Schisandrin B Co-Therapy on
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Apoptosis; Cyclooctanes; Disease Models, Animal; Drug Synergism; Gene Expression Regulation; Inflammasomes; Lignans; Meningoencephalitis; Mice; Mice, Inbred BALB C; Polycyclic Compounds; Pyroptosis; Strongylida Infections; Survival Analysis; Th1 Cells; Th2 Cells | 2020 |
Functional Characterization of Gomisin N in High-Fat-Induced
Topics: Animals; Body Weight; Coconut Oil; Cyclooctanes; Diet, High-Fat; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Energy Metabolism; Gene Expression Regulation; HSP70 Heat-Shock Proteins; Humans; Lignans; Liver; Membrane Proteins; Obesity; Polycyclic Compounds; Schisandra | 2020 |
High-throughput metabolomics discovers metabolite biomarkers and insights the protective mechanism of schisandrin B on myocardial injury rats.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Cyclooctanes; Disease Models, Animal; Lignans; Male; Metabolomics; Myocardium; Polycyclic Compounds; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2021 |
Schisandrin B Attenuates Airway Inflammation and Airway Remodeling in Asthma by Inhibiting NLRP3 Inflammasome Activation and Reducing Pyroptosis.
Topics: Airway Remodeling; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cells, Cultured; Cyclooctanes; Disease Models, Animal; Female; Inflammasomes; Lignans; Lung; Macrophages, Alveolar; MicroRNAs; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Polycyclic Compounds; Pyroptosis; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; TRPC Cation Channels | 2021 |
Schisandrin B Attenuates Airway Inflammation by Regulating the NF-
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cyclooctanes; Disease Models, Animal; Humans; Lignans; Lung; Male; Mice; NF-E2-Related Factor 2; NF-kappa B; Ovalbumin; Oxidative Stress; Polycyclic Compounds; Signal Transduction; Specific Pathogen-Free Organisms | 2021 |
Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers; Caspase 3; Cyclooctanes; Disease Models, Animal; Lignans; Male; NF-kappa B; Oxidative Stress; Polycyclic Compounds; Rats; Signal Transduction; Spinal Cord Injuries; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2017 |
Schisandrin B regulates lipid metabolism in subcutaneous adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Body Weight; Cyclooctanes; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; Glycolysis; Lignans; Lipase; Lipid Metabolism; Lipolysis; Mice; Molecular Structure; Obesity; Oxidation-Reduction; Polycyclic Compounds; Subcutaneous Fat | 2017 |
Schisandrin B down-regulated lncRNA BCYRN1 expression of airway smooth muscle cells by improving miR-150 expression to inhibit the proliferation and migration of ASMC in asthmatic rats.
Topics: Animals; Asthma; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclooctanes; Disease Models, Animal; Down-Regulation; Female; Lignans; MicroRNAs; Myocytes, Smooth Muscle; Polycyclic Compounds; Rats, Sprague-Dawley; RNA, Long Noncoding | 2017 |
Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
Topics: Animals; Biological Availability; Cardiotonic Agents; Cell Death; Cyclooctanes; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Humans; Lignans; Lipids; Matrix Metalloproteinases; Myocardial Infarction; Nanoparticles; Particle Size; Peptides; Polycyclic Compounds; Polyethylene Glycols; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
Schisandrin B protects against myocardial ischemia/reperfusion injury via the PI3K/Akt pathway in rats.
Topics: Animals; Apoptosis; Biomarkers; Creatine Kinase, MB Form; Cyclooctanes; Disease Models, Animal; Lignans; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Troponin T | 2018 |
Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2/Keap1-mediated antioxidant pathway.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Antioxidants; Anxiety; Behavior, Animal; Cyclooctanes; Disease Models, Animal; Glutathione; Kelch-Like ECH-Associated Protein 1; Lignans; Male; Malondialdehyde; Mice, Inbred C57BL; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Polycyclic Compounds; Reactive Oxygen Species; Signal Transduction; Stress, Psychological; Superoxide Dismutase | 2019 |
Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway.
Topics: Animals; Anti-Inflammatory Agents; Cyclooctanes; Disease Models, Animal; Glomerulonephritis, IGA; Kidney; Kidney Function Tests; Lignans; NF-kappa B; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Signal Transduction; Spleen | 2019 |
Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-κB activation.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cyclooctanes; Cytokines; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Gene Expression Regulation; Inflammation; Lignans; Male; Mice; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Oxidative Stress; Phenotype; Polycyclic Compounds; Signal Transduction; Vascular Remodeling | 2019 |
Novel mouse model of combined hyperlipidemia associated with steatosis and liver injury by a single-dose intragastric administration of schisandrin B/cholesterol/bile salts mixture.
Topics: Administration, Oral; Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholesterol; Cyclooctanes; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Fenofibrate; Hyperlipidemias; Lignans; Lipoproteins; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds; Time Factors; Triglycerides | 2013 |
Schisandrin B attenuates acetaminophen-induced hepatic injury through heat-shock protein 27 and 70 in mice.
Topics: Acetaminophen; Administration, Oral; Animals; Chemical and Drug Induced Liver Injury; Cyclooctanes; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Lignans; Liver; Male; Mice; Phytotherapy; Polycyclic Compounds; Schisandra; Time Factors | 2014 |
Gomisin N isolated from Schisandra chinensis augments pentobarbital-induced sleep behaviors through the modification of the serotonergic and GABAergic system.
Topics: Animals; Behavior, Animal; Cyclooctanes; Disease Models, Animal; Drug Synergism; Flumazenil; Fruit; GABA Agents; Hypnotics and Sedatives; Lignans; Male; Mice; Pentobarbital; Polycyclic Compounds; Schisandra; Serotonin Agents; Sleep; Sleep Initiation and Maintenance Disorders | 2014 |
Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiomyopathies; Cyclooctanes; Disease Models, Animal; Doxorubicin; Gene Expression Regulation; Lignans; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Polycyclic Compounds; Tyrosine; Ventricular Function, Left | 2015 |
Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers.
Topics: Animals; Cyclooctanes; Diet, High-Fat; Disease Models, Animal; Fasting; Fatty Acid Synthases; Fatty Acids; Lignans; Lipid Metabolism; Lipids; Lipolysis; Liver; Liver Cirrhosis; Male; Metabolic Networks and Pathways; Metabolomics; Mice; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Polycyclic Compounds; Sterol Regulatory Element Binding Protein 1; Tumor Necrosis Factor-alpha | 2015 |
Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson's disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway.
Topics: 3' Untranslated Regions; Animals; Behavior, Animal; Binding Sites; Brain; Cell Line, Tumor; Cell Survival; Cyclooctanes; Disease Models, Animal; Humans; Lignans; Male; Mice, Inbred C57BL; MicroRNAs; Motor Activity; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidopamine; Parkinsonian Disorders; Polycyclic Compounds; Signal Transduction; Transfection | 2015 |
Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cyclooctanes; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Lignans; Lipopolysaccharides; Lung; Male; Mice, Inbred BALB C; NF-kappa B; Polycyclic Compounds; Receptors, Purinergic P2X7; Signal Transduction | 2016 |
A Naturally-Derived Compound Schisandrin B Enhanced Light Sensation in the pde6c Zebrafish Model of Retinal Degeneration.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 6; Cyclooctanes; Disease Models, Animal; Larva; Lignans; Mutation; Polycyclic Compounds; Retinal Degeneration; Retinal Rod Photoreceptor Cells; Schisandraceae; Vision, Ocular; Zebrafish; Zebrafish Proteins | 2016 |
Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate.
Topics: Animals; Cholesterol; Cyclooctanes; Disease Models, Animal; Dose-Response Relationship, Drug; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Lignans; Liver; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds; Schisandra; Triglycerides | 2011 |
A novel experimental model of acute hypertriglyceridemia induced by schisandrin B.
Topics: Animals; Cyclooctanes; Disease Models, Animal; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Lignans; Lipids; Liver; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds | 2006 |
Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice.
Topics: Animals; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cyclooctanes; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Fenofibrate; Hypercholesterolemia; Hypolipidemic Agents; Lignans; Liver; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds; Schisandra; Triglycerides | 2008 |